← Back to Search

Procedure

MRI for Non-alcoholic Fatty Liver Disease (AWLS Trial)

N/A
Waitlist Available
Led By Kathleen Corey, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 months
Awards & highlights

AWLS Trial Summary

This study is evaluating whether weight loss surgery (WLS) can improve NAFLD in adolescents.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease
  • Obesity

AWLS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in hepatitis steatosis after weight loss surgery

AWLS Trial Design

1Treatment groups
Experimental Treatment
Group I: MRI for steatosis assessmentExperimental Treatment1 Intervention
Abdominal MRI for assessment of hepatic steatosis

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,933 Previous Clinical Trials
13,198,499 Total Patients Enrolled
15 Trials studying Non-alcoholic Fatty Liver Disease
847 Patients Enrolled for Non-alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,315,492 Total Patients Enrolled
47 Trials studying Non-alcoholic Fatty Liver Disease
9,972 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Kathleen Corey, MDPrincipal InvestigatorMassachusetts General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025